Final answer:
Individuals may not complete TB treatment due to the long duration and misperceptions about being cured after initial symptom relief. Enhancing patient education, adopting Directly Observed Treatment, and improving access can increase adherence and reduce drug resistance.
Step-by-step explanation:
Many individuals do not complete a full course of TB drugs due to the lengthy treatment duration, which can last from 6 months to a year. Additionally, once symptoms improve, patients may erroneously believe they are cured and prematurely cease their medication, not understanding the importance of completing the full course to prevent antibacterial resistance. Access to drugs in some regions leads to inconsistent adherence, with many stopping treatment according to symptom relief rather than medical advice.
To increase compliance with TB drug therapy, health systems can adopt measures such as Directly Observed Treatment, Short-Course (DOTS), which involves healthcare providers directly monitoring patient adherence. Educating patients on the importance of completing treatments and the dangers of antibiotic resistance can also enhance compliance. Additionally, leveraging technology for reminders and support, and ensuring treatment is affordable and accessible, are crucial steps to improving adherence and combating the rise of multidrug-resistant TB.